![Allen A. Fienberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Allen A. Fienberg
Corporate Officer/Principal at ITI, Inc. (New York)
Allen A. Fienberg active positions
Companies | Position | Start | End |
---|---|---|---|
ITI, Inc. (New York) | Corporate Officer/Principal | - | - |
Career history of Allen A. Fienberg
Former positions of Allen A. Fienberg
Companies | Position | Start | End |
---|---|---|---|
Intra-Cellular Therapies, Inc. /Old/
![]() Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY. | Founder | 16/03/2011 | 25/09/2013 |
Corporate Officer/Principal | 30/04/2002 | 25/09/2013 | |
The Rockefeller University | Corporate Officer/Principal | 31/12/2001 | 31/12/2001 |
INTRA-CELLULAR THERAPIES, INC. | Corporate Officer/Principal | 04/09/2013 | - |
Novartis Institute for Functional Genomics, Inc.
![]() Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 31/12/1998 | - |
Training of Allen A. Fienberg
Yale University | Doctorate Degree |
University of California, Berkeley | Undergraduate Degree |
Statistics
International
United States | 8 |
Operational
Corporate Officer/Principal | 5 |
Founder | 1 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 4 |
Health Technology | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
INTRA-CELLULAR THERAPIES, INC. | Health Technology |
Private companies | 3 |
---|---|
Intra-Cellular Therapies, Inc. /Old/
![]() Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY. | Health Technology |
Novartis Institute for Functional Genomics, Inc.
![]() Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Commercial Services |
ITI, Inc. (New York) |
- Stock Market
- Insiders
- Allen A. Fienberg
- Experience